Susan Branford
Adelaide, SA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications
Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia.
Journal: HemaSphere
Published: March 18, 2026
Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and nilotinib.
Journal: Leukemia
Published: March 10, 2026
Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia.
Journal: Current hematologic malignancy reports
Published: January 14, 2026
Long-Term Survival Gains after Allogeneic Hematopoietic Stem Cell Transplant are Driven by Reductions in Non-Relapse Mortality: A 35-Year Statewide Australian Cohort Study.
Journal: Transplantation and cellular therapy
Published: November 13, 2025
The PINNACLE study: A multicentre phase II trial of nilotinib in combination with pegylated interferon-α2b in newly diagnosed chronic phase chronic myeloid leukaemia.
Journal: British journal of haematology
Published: September 14, 2025
An old leukaemia in young patients-Genetic characteristics of paediatric chronic myeloid leukaemia.
Journal: British journal of haematology
Published: June 24, 2025
Enhanced Detection of Splice-Altering Variants in Hematologic Malignancies Using Targeted RNA-Sequencing Data.
Journal: The Journal of molecular diagnostics : JMD
Published: February 25, 2025
TRanscriptome ANalysis of StratifiEd CohorTs (TRANSECT) enables automated assessment of global gene regulation linked to disparate expression in user defined genes and gene sets.
Journal: NAR genomics and bioinformatics
Published: October 31, 2024
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?
Journal: Leukemia
Published: February 28, 2024
Last Updated: 09/26/2026